Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
European Huntington's Disease Network, Huntington Study Group investigators
Research output: Contribution to journal › Article › peer-review
83Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study'. Together they form a unique fingerprint.